Evidence map›Paper›PMID 35550611›Full record

ArticleNature cell biology2022

Migratory and anti-fibrotic programmes define the regenerative potential of human cardiac progenitors.

Christine M Poch, Kylie S Foo, Maria Teresa De Angelis, Karin Jennbacken, Gianluca Santamaria, Andrea Bähr, Qing-Dong Wang, Franziska Reiter, Nadja Hornaschewitz, Dorota Zawada and 34 more

Open access · hybridAbstract read
In one paragraph

Article in Nature cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Cardiac commitment driven by MyoD expression in pericardial stem cells.Frontiers in cell and developmental biology · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

44 authors at 11 institutions in 7 countries.

Christine M Poch *Medical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.ORCID 0000-0001-8492-2982
Kylie S Foo *Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Maria Teresa De Angelis *Medical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Karin Jennbacken *Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.ORCID 0000-0003-1254-5158
Gianluca Santamaria *Medical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Andrea Bähr *Medical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Qing-Dong WangResearch and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.ORCID 0000-0001-9570-4411
Franziska ReiterMedical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Nadja HornaschewitzMedical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Dorota ZawadaMedical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Tarik BozogluMedical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Ilaria MyMedical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Anna MeierMedical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.ORCID 0000-0001-6307-3248
Tatjana DornMedical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Simon HegeMedical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Miia L LehtinenDepartment of Medicine, Karolinska Institutet, Huddinge, Sweden.
Yat Long TsoiDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-8890-3989
Daniel HovdalResearch and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.ORCID 0000-0002-8861-4650
Johan HyllnerResearch and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Sascha SchwarzCenter for Applied Tissue Engineering and Regenerative Medicine (CANTER), Munich University of Applied Sciences, Munich, Germany.
Stefanie SudhopCenter for Applied Tissue Engineering and Regenerative Medicine (CANTER), Munich University of Applied Sciences, Munich, Germany.
Victoria JurischMedical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Marcella SiniClinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Mick D FellowsClinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Matthew CummingsWestern Michigan School of Medicine, Kalamazoo, MI, USA.
Jonathan ClarkeProcella Therapeutics, Stockholm, Sweden.
Ricardo BaptistaProcella Therapeutics, Stockholm, Sweden.
Elif ErogluDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-3952-3178
Eckhard WolfChair for Molecular Animal Breeding and Biotechnology, Gene Center and Department of Veterinary Sciences, LMU Munich, Munich, Germany.ORCID 0000-0002-0430-9510
Nikolai KlymiukMedical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Kun LuWalter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, Munich, Germany.
Roland TomasiWalter-Brendel-Centre of Experimental Medicine, University Hospital, LMU Munich, Munich, Germany.
Andreas DendorferDZHK (German Centre of Cardiovascular Research), Munich Heart Alliance, Munich, Germany.ORCID 0000-0002-7806-312X
Marco GaspariDepartment of Experimental and Clinical Medicine, University of Magna Grecia, Catanzaro, Italy.ORCID 0000-0002-5411-8800
Elvira ParrottaDepartment of Experimental and Clinical Medicine, University of Magna Grecia, Catanzaro, Italy.
Giovanni CudaDepartment of Experimental and Clinical Medicine, University of Magna Grecia, Catanzaro, Italy.ORCID 0000-0001-6313-1866
Markus KraneDZHK (German Centre of Cardiovascular Research), Munich Heart Alliance, Munich, Germany.
Daniel SinneckerMedical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.ORCID 0000-0002-8116-9750
Petra HoppmannMedical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Christian KupattMedical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. Christian.Kupatt@tum.de.ORCID 0000-0002-3611-1218
Regina Fritsche-DanielsonResearch and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. Regina.Fritsche-Danielson@astrazenca.com.ORCID 0000-0003-0582-6429
Alessandra MorettiMedical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. amoretti@mytum.de.ORCID 0000-0001-5782-7832
Kenneth R ChienDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden. kenneth.chien@ki.se.ORCID 0000-0002-2759-8378
Karl-Ludwig LaugwitzMedical Department I, Cardiology, Angiology, Pneumology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. KL.Laugwitz@mri.tum.de.ORCID 0000-0003-4948-4846
TUM Klinikum · DEKarolinska Institutet · SEAstraZeneca (Sweden) · SELudwig-Maximilians-Universität München · DEMagna Graecia University · ITAstraZeneca (United Kingdom) · GBGerman Centre for Cardiovascular Research · DEMunich University of Applied Sciences · DEAstraZeneca (Brazil) · BRLinköping University · SEWestern Michigan University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart regeneration is an unmet clinical need, hampered by limited renewal of adult cardiomyocytes and fibrotic scarring. Pluripotent stem cell-based strategies are emerging, but unravelling cellular dynamics of host-graft crosstalk remains elusive. Here, by combining lineage tracing and single-cell transcriptomics in injured non-human primate heart biomimics, we uncover the coordinated action modes of human progenitor-mediated muscle repair. Chemoattraction via CXCL12/CXCR4 directs cellular migration to injury sites. Activated fibroblast repulsion targets fibrosis by SLIT2/ROBO1 guidance in organizing cytoskeletal dynamics. Ultimately, differentiation and electromechanical integration lead to functional restoration of damaged heart muscle. In vivo transplantation into acutely and chronically injured porcine hearts illustrated CXCR4-dependent homing, de novo formation of heart muscle, scar-volume reduction and prevention of heart failure progression. Concurrent endothelial differentiation contributed to graft neovascularization. Our study demonstrates that inherent developmental programmes within cardiac progenitors are sequentially activated in disease, enabling the cells to sense and counteract acute and chronic injury.

Indexed as

Nerve Tissue ProteinsPluripotent Stem CellsAnimalsCell DifferentiationCicatrixFibrosisHumansMyocardiumMyocytes, CardiacReceptors, ImmunologicSwineNerve Tissue ProteinsReceptors, Immunologic

Identifiers

PMID35550611
PMCPMC9106586
OpenAlexW4280594082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.